Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
A one-day meeting sharing key updates from the recent ASH conference, with a focus on clinical data most relevant to a Scottish audience. The programme covers myeloma alongside updates in ALL, myeloproliferative neoplasms, acute myeloid leukaemia, CLL, high-grade lymphoma and low-grade lymphoma.
For myeloma HCPs, the session is chaired by Dr Chris McDermott (Beatson West of Scotland Cancer Centre) and includes:
First line myeloma advances, presented by Dr Sally Moore (University Hospitals Bristol).
Relapsed and refractory myeloma, presented by Dr Jennifer Travers (Beatson West of Scotland Cancer Centre).
